Can-Fite Biopharma Ltd ADR (CANF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CANF | SNOA | INDP | ||
| Company | Can-Fite Biopharma Ltd ADR | Sonoma Pharmaceuticals Inc | Indaptus Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NYSE Arca | NASDAQ | NASDAQ | ||
| Open | 3.21 | 2.49 | 1.6750 | ||
| High | 3.27 | 2.49 | 1.6800 | ||
| Low | 3.18 | 2.32 | 1.6750 | ||
| Latest | 3.27 | 2.34 | 1.6800 | ||
| Change | +0.03 | -0.21 | -0.0500 | ||
| % Change | +0.93% | -8.24% | -2.89% | ||
| Volume | 18,376 | 219,567 | 3,511 | ||
| 20-Day Average Volume | 2,050,569 | 25,168 | 46,541 | ||
| Previous Close | 3.24 | 2.55 | 1.7300 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 4.12 | 2.58 | 1.8678 | ||
| 20-Day Raw Stochastic | 1.66% | 5.12% | 10.72% | ||
| 20-Day Relative Strength | 38.41 | 36.06 | 41.45 | ||
| Weighted Alpha | -86.98 | -60.36 | -84.37 | ||
| Today's Opinion | 100% Sell | 100% Sell | 100% Sell | ||
| Previous Opinion | 100% Sell | 100% Sell | 100% Sell | ||
| Last Month's Opinion | 56% Sell | 100% Sell | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -4.66% since 03/17/26 | -2.74% since 03/17/26 | -14.29% since 03/17/26 | ||
| Low | 3.15 on 03/20/26 | 2.32 on 03/24/26 | 1.6200 on 03/20/26 | ||
| High | 3.53 on 03/18/26 | 2.56 on 03/23/26 | 1.9900 on 03/18/26 | ||
| 1-Month | |||||
| %Chg | -25.51% since 02/24/26 | -17.81% since 02/24/26 | -16.42% since 02/24/26 | ||
| Low | 3.15 on 03/20/26 | 2.30 on 03/06/26 | 1.6200 on 03/20/26 | ||
| High | 10.40 on 03/04/26 | 3.06 on 03/02/26 | 2.1799 on 02/26/26 | ||
| 3-Month | |||||
| %Chg | -9.32% since 12/24/25 | -35.87% since 12/24/25 | -36.60% since 12/24/25 | ||
| Low | 3.15 on 03/20/26 | 2.30 on 03/06/26 | 1.5200 on 02/06/26 | ||
| High | 10.40 on 03/04/26 | 3.89 on 01/05/26 | 3.6600 on 01/16/26 | ||
| 6-Month | |||||
| %Chg | -73.53% since 09/24/25 | -42.79% since 09/24/25 | -43.24% since 09/24/25 | ||
| Low | 3.15 on 03/20/26 | 2.30 on 03/06/26 | 1.5200 on 02/06/26 | ||
| High | 12.80 on 09/30/25 | 4.60 on 10/06/25 | 8.5700 on 09/26/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 4,242 | 4,413 | 3,879 | ||
| Shares Outstanding, K | 1,309 | 1,731 | 2,242 | ||
| Annual Sales | 670,000 | 14,290,000 | 0 | ||
| Annual Net Income | -7,880,000 | -3,460,000 | -20,850,000 | ||
| Last Quarter Sales | 160,000 | 4,350,000 | 0 | ||
| Last Quarter Net Income | -1,650,000 | -820,000 | -8,110,000 | ||
| 60-Month Beta | 1.01 | 1.66 | 0.97 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.35 on 02/10/26 | -3.10 on 03/17/26 | ||
| Latest Earnings Date | 04/13/26 | 06/16/26 | 05/13/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||